News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, April 5, 2021

ORA Research News - Monday, April 5, 2021

ORA Noon Conference offered via Zoom

SAVE THE DATE!  April 21, 2021 at 1:00 pm

Topic: Writing NIH Other Support Pages

Required Changes as of May 25, 2021

Office of Technology Commercialization presents two opportunities to engage with industry (click here for more information, or email otc@ou.edu or meredith-wilkerson@ouhsc.edu).  

  1. Syngenta is seeking to engage with academic partners to:
  • Develop tools for the precise control of transgenic trait genes via a high throughput regulatory element evaluation system in plants.
  • Develop gene promoters and other regulatory elements that confer high expression levels in desired tissues without impacting pollen production in plants.  Out of scope: viral regulatory elements, candidates lacking demonstrated performance in plants.

Proposal template available upon request (submission deadline (4/12/2021).

  1. Pfizer’s Centers for Therapeutic Innovation (https://www.pfizercti.com) is seeking collaborative proposals for developing novel therapeutic targets with application in:
  • Oncology: tumor targeted, immuno-oncology, cancer vaccines
  • Internal medicine: obsesity/cachexia, heart failure, diabetic/CKD, NASH/T2D
  • Inflammation and immunology: rheumatology, gastroenterology, medical derm
  • Rare disease: cardiology, neuro-musc., metabolic, hematology

Preference is for novel biological targets supported by in vivo and in vitro models, enabling genetics and mechanistic insights, translational biochemical or cellular assay and biomarkers.  Out of scope: drug repurposing, standalone biomarker assays/platforms, medical devices, cell-based therapies. 

Proposal template available upon request (submission deadline 6/18/21).

OCAST’s Oklahoma Applied Research Support (OARS) program specifications have changed.  Please refer to the attached document.

OUHSC HSC COVID-19 Return Plan - now the HSC COVID-19 Response Plan - effective February 16, 2021. 

This revised Plan (https://www.ouhsc.edu/coronavirus) includes some minor clarifications to current HSC COVID-19 protocols, as well as some more substantive revisions, including: Adoption and implementation of updated testing and quarantine/isolation protocols following employee and student return from international travel and from cruises, based on recent federal executive order requirements (Sections VIII, IX).  Please note that under the new protocols, individuals returning from international travel or from domestic or international cruises will typically have to quarantine/isolate from campus for 7 calendar days and receive a negative test prior to return. Individuals traveling internationally or taking cruises must be prepared to take leave (paid or unpaid, as appropriate) during the quarantine/isolation period communicated by Student/Employee Health, particularly if their position or responsibilities are not approved for or appropriate for remote work. Students must be prepared to be away from academic and clinical responsibilities during the designated quarantine/isolation period.

Requirement that even those fully vaccinated must complete the online COVID-19 Screening and Reporting Tool (Sections VII, IX).  At this time, the CDC has issued limited guidance on how completion of the COVID-19 vaccine series will impact exposure assessment.  We will continue to monitor and will make adjustments to this requirement as needed. The Travel FAQs and the instructions for when to complete the online COVID-19 Screening and Reporting Tool, have been updated. The Tool itself has already been updated to reflect the changes above.

PRESBYTERIAN HEALTH FOUNDATION GRANTS – REQUEST FOR APPLICATIONS

The Presbyterian Health Foundation (PHF) will fund $4.15M in grants for 2021.  Information on the PHF Grant Programs for Spring 2021 and Guidelines and Application for each of the grant programs listed below may be found at https://research.ouhsc.edu/Resources/PHF-Funding-2021.  All guidelines have been recently updated to reflect that funds may not be requested for student tuition and fees. If you have any questions, please email ORA4PHF@ouhsc.edu.

Grant Type

Deadline

Clinician Scientist Development

April 9, 2021

Team Science

April 9, 2021

Bridge

April 30, 2021

REMINDER ON COVID-19 MITIGATION STRATEGIES IN THE RESEARCH ENVIRONMENT

With the current increase in COVID-19 cases across Oklahoma, this is a good time to do the following:

  • Encourage everyone on your team to telecommute as much as possible; reducing the number of individuals in buildings and the research environment will help in reducing potential transmission of the virus.
  • Follow your approved COVID-19 Standard Operating Procedures for your laboratory; be certain these are current and are posted on the lab door and inside the laboratory.
  • Familiarize yourself with OU Health Sciences Center COVID-19 Resources 
  • https://www.ouhsc.edu/coronavirus).
  • Follow all masking and social distancing guidelines as described in the OUHSC COVID-19 Return Plan (https://www.ouhsc.edu/coronavirus); wash your hands often.
  • It’s a good practice to follow the HSC’s COVID-19 protocols even when you are home or in the community – masking, social distancing, and good hand hygiene help protect you, your colleagues, and your loved ones.

Oklahoma Covid-19 Working Group

Information on research activities in Oklahoma that address the Covid-19 pandemic has been added to the  OCTSI Website (http://octsi.ouhsc.edu/covid-19%20working%20group) A list of investigators in the working group and their planned or ongoing projects are described. A list of funded Covid-19 Seed Projects at OUHSC and OU Norman is also included. To be added to the Oklahoma Covid-19 Working Group or to have your information updated, please contact: Mark L. Lang PhD, Presbyterian Health Foundation Presidential Professor, Department of Microbiology and Immunology, OUHSC ( mark-lang@ouhsc.edu ).

Up to date information on allowable OUHSC research activity in response to COVID-19 can be found at:  

https://research.ouhsc.edu/Resources/COVID-Research-Updates

NIH NOTICES

Updated Reporting Requirements for RADx-rad Grant Recipients (NOT-OD-21-084)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-084.html

Continued Extension of Certain Flexibilities for Prospective Basic Experimental Studies With Human Participants (NOT-OD-21-088)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-088.html

Notice of Information: NIAAA Clinical Medications Development Testing Program (NOT-AA-21-008)

https://grants.nih.gov/grants/guide/notice-files/NOT-AA-21-008.html

Notice of Pre-Application Information Webinar for PAR-21-092, "NIDA Translational Avant-Garde Award for Development of Medication to

Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)"
(NOT-DA-21-025)

https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-025.html

Updated NHLBI Guidance Concerning Mentored Career Development (K08 and K23) Awards: Percent Effort (NOT-HL-21-003)

https://grants.nih.gov/grants/guide/notice-files/NOT-HL-21-003.html

Updated Notice of Limited Availability of Research Non-Human Primates (NOT-OD-21-080)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-080.html

Expansion of Eligibility: Technical and Business Assistance (TABA) Needs Assessment Program for National Institutes of Health (NIH) Small

Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees (NOT-OD-21-082)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-082.html

Request for Information: Challenges and Opportunities in Understanding Cellular Senescence and Senolytics (NOT-RM-21-016)

https://grants.nih.gov/grants/guide/notice-files/NOT-RM-21-016.html


Notice of Clarification of Research Priorities for RFA-AA-21-002 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use

(R01 Clinical Trial Not Allowed)" (NOT-AA-21-009)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-21-009.html

Notice of Clarification of Research Priorities for RFA-AA-21-003 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use

(R03 Clinical Trial Not Allowed)" (NOT-AA-21-010)

https://grants.nih.gov/grants/guide/notice-files/NOT-AA-21-010.html

Notice of Clarification of Research Priorities for RFA-AA-21-004 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use

(R21 Clinical Trial Not Allowed)" (NOT-AA-21-011)

https://grants.nih.gov/grants/guide/notice-files/NOT-AA-21-011.html

Notice of Early Expiration of PAR-19-346 "Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity

(R21 Clinical Trial Not Allowed)" (NOT-AI-21-033)

https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-033.html

Notice of Early Expiration of PAR-19-347 "Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity

(R03 Clinical Trial Not Allowed)" (NOT-AI-21-034)

https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-034.html

Notice of Early Expiration of PA-19-068, Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research

(R21 Clinical Trial Not Allowed) (NOT-AI-21-040)

https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-040.html

Notice of Change to Eligibility Information in RFA-AI-20-080, "Human Immunology Project Consortium (HIPC) Coordinating Center

(U01 Clinical Trial Not Allowed)" (NOT-AI-21-043)

https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-043.html

Notice of Extension of Application Due Date for RFA-DK-20-034, "Program to Advance the Career Development of Scientists from Diverse

Backgrounds Conducting Nutrition, Obesity, Diabetes, and Related Research (U24 Clinical Trial Optional)" (NOT-DK-21-017)

https://grants.nih.gov/grants/guide/notice-files/NOT-DK-21-017.html

Notice of Change to the Application Due Date(s) for PAR-20-083 titled "Enhancing Regulatory Science for Advancing Pharmaceutical

Quality and Manufacturing (U01 Clinical Trials Optional) (NOT-FD-21-013)
https://grants.nih.gov/grants/guide/notice-files/NOT-FD-21-013.html

Notice of NICHD Participation in PAR-20-266, "Promoting Research on Music and Health: Phased Innovation Award for Music

Interventions (R61/R33 Clinical Trial Optional)" (NOT-HD-21-021)

https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-021.html

Notice of NICHD Participation in PAR-21-099, "Music and Health: Understanding And Developing Music Medicine

(R21 Clinical Trial Optional) (NOT-HD-21-022)

https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-022.html

Notice of NICHD Participation in PAR-21-100, "Music and Health: Understanding And Developing Music Medicine

(R01 Clinical Trial Optional)" (NOT-HD-21-023)

https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-023.html

Notice of Change to AIDS Date of RFA-MH-21-120, "Mental Health Research Awards for Investigators Early in their

Career in Low and Middle-Income Countries (R01 Clinical Trial Optional)" (NOT-MH-21-240)

https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-240.html

Notice of Change to Key Dates for RFA-NS-20-006 "BRAIN Initiative: Biology and Biophysics of Neural Stimulation and

Recording Technologies (R01 Clinical Trials Optional)" (NOT-NS-21-046)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-046.html

Notice of Corrections to PAR-20-181, Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)

(NOT-OD-21-081)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-081.html

Notice of Change: Change in Data Table Submission Requirements for PAR-21-120, Global Infectious Disease Research

Training Program (D43 Clinical Trial Optional) (NOT-TW-21-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-TW-21-005.html

Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiative (Phase II)
(NOT-OD-21-064)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-064.html

Notice of Intent to Publish a Funding Opportunity Announcement for PHS 2021 Omnibus Solicitations of the NIH, CDC, and

FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications

(NOT-OD-21-083)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-083.html

Notice of Special Interest (NOSI): Investigations on Inborn Errors of Immunity/Primary Immunodeficiencies (NOT-AI-21-032)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-032.html

Notice of Special Interest (NOSI): Administrative Supplement for Genome-wide Genotyping of Existing Samples from Minority

Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data
(NOT-CA-21-049)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-049.html

Notice of Special Interest (NOSI): Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects

(NOT-DA-21-028)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-028.html

Notice of Special Interest (NOSI): Administrative Supplements for Research on Fentanyl and Derivatives
(NOT-DA-21-032)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-032.html

Notice of Special Interest (NOSI): Basic Research on Fentanyl and Synthetic Fentanyl Analogs: Signaling, Neurobiology, and

Pharmacology (NOT-DA-21-033)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-033.html

Notice of Special Interest (NOSI): Stimulate Research on the Diagnosis, Treatment, and Mechanistic Understanding of Postural

Orthostatic Tachycardia Syndrome (POTS) (NOT-HL-21-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-21-008.html


Notice of Special Interest (NOSI): Characterization of Genomics of Induced Pluripotent Stem Cell Lines for AD/ADRD Research

(NOT-NS-21-041)

https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-041.html

Notice of Special Interest (NOSI): Administrative Supplement for Providing Technical and Business Assistance (TABA) Funding to

SBIR/STTR Awardees (Admin Supp) (NOT-OD-21-062)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-062.html

Notice of Special Interest (NOSI): Administrative Supplements for COVID-19-Impacted FIC Research Training and Education Awards

(NOT-TW-21-003)

https://grants.nih.gov/grants/guide/notice-files/NOT-TW-21-003.html

Notice of Special Interest (NOSI): Administrative Supplements to FIC Awards for COVID-19-related Research in Low- or Middle-Income

Countries (NOT-TW-21-004)

https://grants.nih.gov/grants/guide/notice-files/NOT-TW-21-004.html

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least two months prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

NIH DEADLINES

NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00)
(PAR-21-143)- Deadline August 8, 2021 and December 8, 2021

https://grants.nih.gov/grants/guide/pa-files/PAR-21-143.html

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

(PAR-21-166) - Deadline June 5, 2021 and October 5, 2021

https://grants.nih.gov/grants/guide/pa-files/PAR-21-166.html

Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)
(PAR-21-183 – Deadline August 4, 2021 and December 6, 2021

https://grants.nih.gov/grants/guide/pa-files/PAR-21-183.html

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

(PAR-21-206) - Deadline June 5, 2021 and October 5, 2021

https://grants.nih.gov/grants/guide/pa-files/PAR-21-206.html

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) (PAR-21-208)
Deadline August 20, 2021 and March 8, 20222

https://grants.nih.gov/grants/guide/pa-files/PAR-21-208.html

Limited Competition: Alzheimer’s Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative

(U01 Clinical Trial Not Allowed) (PAR-21-212) – Deadline June 5, 2021 and October 5, 2021

https://grants.nih.gov/grants/guide/pa-files/PAR-21-212.html

Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed)

(RFA-AG-22-009) – Deadline October 4, 2021 

https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-009.html

Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias

(R25 - Clinical Trial Not Allowed) (RFA-AG-22-010) - Deadline October 4, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-010.html

Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)

(RFA-AT-21-006) - Deadline July 14, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-21-006.html

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization

(R44 Clinical Trial Optional) (RFA-CA-21-036) - Deadline August 6, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-036.html

Strategies that Support Global Food Safety (U01) Clinical Trial Not Allowed (RFA-FD-21-030)
Deadline May 24, 2021 

https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-21-030.html

AAV Vector Manufacturing for Diseases Affecting Very Small Populations (R01) Clinical Trials Not Allowed (RFA-FD-21-034)

Deadline May 28, 2021 

https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-21-034.html

Recompetition of the Pediatric Scientist Development Program (PSDP) (K12 Clinical Trial Not Allowed)
(RFA-HD-22-006) - Deadline July 29, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-22-006.html

NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed)

(RFA-LM-21-001) – Deadline May 14, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-LM-21-001.html

Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities

(R01 Clinical Trial Optional) (RFA-MD-21-004) - Deadline August 24, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-MD-21-004.html

Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed) (RFA-RM-21-021)

Deadline May 28, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-21-021.html

Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions

(U01 Clinical Trial Allowed) (RFA-RM-21-022) – Deadline May 28, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-21-022.html

Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research

(Collaborative U01 Clinical Trial Optional) (RFA-TW-21-001)
Deadline July 8, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-TW-21-001.html

Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research

Training (Collaborative U2R Clinical Trial Optional) (RFA-TW-21-002)
Deadline July 8, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-TW-21-002.html

OTHER FEDERAL DEADLINES

Department of Defense (DOD) – Peer Reviewed Cancer Research Program (PRCRP) – Behavioral Health Sciences Award

PreApplication due July 29, 2021

https://cdmrp.army.mil/funding/prcrp

DOD – PRCRP – Career Development Award/Fellow Option – PreApplication due July 29, 2021

https://cdmrp.army.mil/funding/prcrp

DOD – PRCRP – Idea Award – PreApplication due May 20, 2021

https://cdmrp.army.mil/funding/prcrp

DOD – PRCRP – Impact Award – PreApplication due May 20, 2021

https://cdmrp.army.mil/funding/prcrp

DOD – PRCRP – Translational Team Science Award – PreApplication due July 29, 2021

https://cdmrp.army.mil/funding/prcrp

DOD – Spinal Cord Injury Research Program (SCIRP) – Clinical Trial Award – PreApplication due May 24, 2021

https://cdmrp.army.mil/funding/scirp

DOD – SCIRP – Translational Research Award – PreApplication due May 24, 2021

https://cdmrp.army.mil/funding/scirp

DOD – SCIRP – Investigator Initiated Research Award – PreApplication due May 24, 2021

https://cdmrp.army.mil/funding/scirp

OTHER DEADLINES

Alzheimer’s Drug Discovery Foundation – Harrington Scholar Award – Letter of Intent Deadline April 23, 2021

https://mailchi.mp/alzdiscovery/april-23-deadline-approaching-for-2021-addf-harrington-scholar-award?e=8730f4571b

American Cancer Society (ACS) – Research Scholar Grant – Deadline October 15, 2021

https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/grant-application-deadlines.html

ACS – Clinician Scientist Development Grant – Deadline October 15, 2021

https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/grant-application-deadlines.html

ACS – Postdoctoral Fellowship – Deadline October 15, 2021

https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/grant-application-deadlines.html

ACS – Clinical Research Professor Award – Letter of Intent Deadline October 15, 2021

https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/grant-application-deadlines.html

Print